David M. Goldstein

Direttore Tecnico/Scientifico/R&S presso PRINCIPIA BIOPHARMA INC.

58 anni

Health Technology

Consumer Services

Relazioni attive

Nome	Sesso	Età	Società collegate	Collaborazione
Severin Schwan	M	57	ROCHE HOLDING AG	16 anni
Chris Varma	M	-	Frontier Medicines Corp. Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA.	6 anni
André S. Hoffmann	M	66	ROCHE HOLDING AG	28 anni
Othman Laraki	M	46	Frontier Medicines Corp. Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA.	-
Betsy Santos	F	-	PRINCIPIA BIOPHARMA INC.	-
Daniel K. Nomura	M	-	Frontier Medicines Corp. Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA.	6 anni
Roberto Zoncu	M	-	Frontier Medicines Corp. Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA.	6 anni
Thomas Schinecker	M	49	ROCHE HOLDING AG	21 anni
Luke Evnin	M	60	Frontier Medicines Corp. Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA.	-
John Reed	M	65	PRINCIPIA BIOPHARMA INC.	-
Paul Laland	M	-	PRINCIPIA BIOPHARMA INC.	-
Pamela Klein	M	63	Frontier Medicines Corp. Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA.	1 anni
Janwillem Naesens	M	41	Frontier Medicines Corp. Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA.	-
Cameron Wheeler	M	45	Frontier Medicines Corp. Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA.	-
Setareh Pouraghabagher	F	53	Frontier Medicines Corp. Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA.	2 anni
Joan S Brugge	M	-	Frontier Medicines Corp. Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA.	-

Mostra altro

Grafico relazionale

Relazione in diverse aziende

Relazioni precedenti

Nome	Sesso	Età	Società collegate	Collaborazione
DeAnne Shirley Julius	M	75	ROCHE HOLDING AG	14 anni
Erich Hunziker	M	70	ROCHE HOLDING AG	10 anni
Andreas Oeri	M	75	ROCHE HOLDING AG	24 anni
Walter Frey	M	80	ROCHE HOLDING AG	10 anni
John Bell	M	71	ROCHE HOLDING AG	19 anni
Lodewijk J. R. de Vink	M	78	ROCHE HOLDING AG	9 anni
Christopher Chai	M	58	PRINCIPIA BIOPHARMA INC.	7 anni
Martin Babler	M	59	PRINCIPIA BIOPHARMA INC.	9 anni
Peter Thompson	M	64	PRINCIPIA BIOPHARMA INC.	8 anni
Paul Bulcke	M	69	ROCHE HOLDING AG	11 anni
Horst Teltschik	M	83	ROCHE HOLDING AG	-
Simeon George	M	46	PRINCIPIA BIOPHARMA INC.	9 anni
Wolfgang Ruttenstorfer	M	73	ROCHE HOLDING AG	4 anni
Christoph Franz	M	64	ROCHE HOLDING AG	12 anni
Roy C. Hardiman	M	64	PRINCIPIA BIOPHARMA INC.	5 anni
Pius Baschera	M	73	ROCHE HOLDING AG	10 anni
Bruno Gehrig	M	77	ROCHE HOLDING AG	9 anni
Domenico Scala	M	59	ROCHE HOLDING AG	8 anni
John Smither	M	71	PRINCIPIA BIOPHARMA INC.	-
Henri-Paul Meier	M	-	ROCHE HOLDING AG	-
Dan Becker	M	49	PRINCIPIA BIOPHARMA INC.	3 anni
Clive Meanwell	M	67	ROCHE HOLDING AG	9 anni
Arthur Levinson	M	73	ROCHE HOLDING AG	-
Alan Colowick	M	61	PRINCIPIA BIOPHARMA INC.	3 anni
William Burns	M	76	ROCHE HOLDING AG	4 anni
Beatrice Weder di Mauro	M	57	ROCHE HOLDING AG	10 anni
Vincent Charlon	M	-	ROCHE HOLDING AG	8 anni
Steve Krognes	M	56	ROCHE HOLDING AG	5 anni
Jean-Jacques Garaud	M	68	ROCHE HOLDING AG	5 anni
Klaus Gustav Strein	M	-	ROCHE HOLDING AG	13 anni
Unni Hjelmaas	F	-	ROCHE HOLDING AG	3 anni
Michael Burgess	M	61	ROCHE HOLDING AG	-
David Kabakoff	M	76	PRINCIPIA BIOPHARMA INC.	2 anni
Torsten Hoffmann	M	57	ROCHE HOLDING AG	16 anni
Greg S. Yap	M	-	ROCHE HOLDING AG	3 anni
Shawn Tomasello	F	65	PRINCIPIA BIOPHARMA INC.	1 anni
Michael Mulqueen	M	-	ROCHE HOLDING AG	13 anni
Michael Byrnes	M	47	PRINCIPIA BIOPHARMA INC.	-
Olivia Ware	F	67	PRINCIPIA BIOPHARMA INC.	2 anni
Luca Santarelli	M	55	ROCHE HOLDING AG	8 anni
Shao Lee Lin	M	57	PRINCIPIA BIOPHARMA INC.	1 anni
Christopher Vann	M	59	ROCHE HOLDING AG	22 anni
Stefani Wolff	F	62	PRINCIPIA BIOPHARMA INC.	4 anni
Dolca Thomas	M	53	PRINCIPIA BIOPHARMA INC.	2 anni
Marc M. Gibeley	M	59	ROCHE HOLDING AG	5 anni
Anton Affentranger	M	68	ROCHE HOLDING AG	-
Dirk W. Kirsten	M	56	ROCHE HOLDING AG	2 anni
Bradley Bolzon	M	64	ROCHE HOLDING AG	4 anni
Peter Brabeck-Letmathe	M	79	ROCHE HOLDING AG	10 anni
Clarence Machado	M	60	PRINCIPIA BIOPHARMA INC.	1 anni
Lewis J. Shuster	M	68	PRINCIPIA BIOPHARMA INC.	-
Stephen Hill	M	65	ROCHE HOLDING AG	2 anni
Hany Massarany	M	62	ROCHE HOLDING AG	2 anni
Franz Humer	M	76	ROCHE HOLDING AG	19 anni
Richard Scheller	M	70	ROCHE HOLDING AG	5 anni
Rolf Hänggi	M	81	ROCHE HOLDING AG	10 anni
Per-Olof Attinger	M	64	ROCHE HOLDING AG	-
Eduard Enrico Holdener	M	79	ROCHE HOLDING AG	12 anni
Rolf Schläpfer	M	68	ROCHE HOLDING AG	-
Gerald Heinz Möller	M	80	ROCHE HOLDING AG	-
Phyllis Whiteley	M	-	ROCHE HOLDING AG	5 anni
Jürg Witmer	M	75	ROCHE HOLDING AG	21 anni
Myriam Meyer Stutz	M	62	ROCHE HOLDING AG	3 anni
Steven G. Gourlay	M	64	PRINCIPIA BIOPHARMA INC.	5 anni
Michael Dybbs	M	49	PRINCIPIA BIOPHARMA INC.	2 anni
Mohammad Masjedizadeh	M	-	PRINCIPIA BIOPHARMA INC.	5 anni

Statistiche

Paese	Relazioni	% del totale
Svizzera	49	59.76%
Stati Uniti	33	40.24%

Età delle relazioni

Attive

Scorse

Uomo

Donna

Amministratori

Dirigenti

Provenienza delle relazioni